Compile Data Set for Download or QSAR
maximum 50k data
Found 100 with Last Name = 'damann' and Initial = 'n'
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176564(US9120756, 26)
Affinity DataKi:  0.100nM ΔG°:  -59.4kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176555(US9120756, 17)
Affinity DataKi:  0.100nM ΔG°:  -59.4kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342149(1-((2-(tert-butyl)-4-(3-chlorophenyl)thiazol-5-yl)...)
Affinity DataKi:  0.100nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176564(US9120756, 26)
Affinity DataKi:  0.100nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176555(US9120756, 17)
Affinity DataKi:  0.100nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176554(US9120756, 16)
Affinity DataKi:  0.200nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176559(US9120756, 21)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342128(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  0.300nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176554(US9120756, 16)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176561(US9120756, 23)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176562(US9120756, 24)
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176549(US9120756, 7)
Affinity DataKi:  0.350nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342122(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  0.400nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176566(US9120756, 28)
Affinity DataKi:  0.400nM ΔG°:  -55.8kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176562(US9120756, 24)
Affinity DataKi:  0.400nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176561(US9120756, 23)
Affinity DataKi:  0.400nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176556(US9120756, 18)
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342117(N-((2-(tert-butyl)-4-(3-chlorophenyl)thiazol-5-yl)...)
Affinity DataKi:  0.600nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342119(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  0.700nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342122(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  0.700nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342121(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)oxazol-5...)
Affinity DataKi:  0.700nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176571(US9120756, 40)
Affinity DataKi:  0.800nM ΔG°:  -54.0kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342120(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  1.10nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176559(US9120756, 21)
Affinity DataKi:  1.20nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176567(US9120756, 29)
Affinity DataKi:  1.20nM ΔG°:  -53.0kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176565(US9120756, 27)
Affinity DataKi:  1.20nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342115(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  1.40nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176553(US9120756, 15)
Affinity DataKi:  2.10nM ΔG°:  -51.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176565(US9120756, 27)
Affinity DataKi:  2.20nM ΔG°:  -51.4kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342151(N-(4-(3-((2-(tert-butyl)-4-(m-tolyl)thiazol-5-yl)m...)
Affinity DataKi:  2.30nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342130(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)thiazol-...)
Affinity DataKi:  2.35nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176553(US9120756, 15)
Affinity DataKi:  2.5nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176583(US9120756, 134)
Affinity DataKi:  2.5nM ΔG°:  -51.1kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176552(US9120756, 14)
Affinity DataKi:  3.70nM ΔG°:  -50.1kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176569(US9120756, 33)
Affinity DataKi:  4nM ΔG°:  -49.9kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342129(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)oxazol-5...)
Affinity DataKi:  4.70nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176563(US9120756, 25)
Affinity DataKi:  5.10nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342121(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)oxazol-5...)
Affinity DataKi:  5.20nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176550(US9120756, 12)
Affinity DataKi:  5.90nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342147(1-((2-(tert-butyl)-4-(3-chlorophenyl)thiazol-5-yl)...)
Affinity DataKi:  5.90nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176568(US9120756, 30)
Affinity DataKi:  6.30nM ΔG°:  -48.7kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342150(N-(4-(3-((2-(tert-butyl)-4-(3-chlorophenyl)thiazol...)
Affinity DataKi:  6.60nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal

US Patent
LigandPNGBDBM176552(US9120756, 14)
Affinity DataKi:  7.20nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176570(US9120756, 39)
Affinity DataKi:  7.20nM ΔG°:  -48.3kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342118(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)oxazol-5...)
Affinity DataKi:  7.5nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176550(US9120756, 12)
Affinity DataKi:  8nM ΔG°:  -48.1kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342144(N-((5-(3-chlorophenyl)-2-(tertbutyl)thiazol-5-yl)m...)
Affinity DataKi:  9.10nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342148(1-((2-(tert-butyl)-4-(3-chlorophenyl)thiazol-5-yl)...)
Affinity DataKi:  12.3nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM176585(US9120756, 141)
Affinity DataKi:  13.6nM ΔG°:  -46.7kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal

US Patent
LigandPNGBDBM342127(N-((4-(3-chlorophenyl)-2-(trifluoromethyl)oxazol-5...)
Affinity DataKi:  13.8nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: